-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M1hVmpkYix174SWCFoIrFXunQ8O1rw/PHTq+f+t8NF+aD2q64xDtZAp9LDuVeFXL 4dmq0/GFU1QaLCHcNBN/8Q== 0000881153-99-000005.txt : 19990416 0000881153-99-000005.hdr.sgml : 19990416 ACCESSION NUMBER: 0000881153-99-000005 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990415 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SANGSTAT MEDICAL CORP CENTRAL INDEX KEY: 0000913610 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943076069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-45205 FILM NUMBER: 99594275 BUSINESS ADDRESS: STREET 1: 1505 ADAMS DR CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6503280300 MAIL ADDRESS: STREET 1: 1505 ADAMS DR CITY: MENLO PARK STATE: CA ZIP: 94025 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: UBS BRINSON INC CENTRAL INDEX KEY: 0000881153 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 132725861 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 10 E 50TH ST CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123351210 MAIL ADDRESS: STREET 1: 10 E 50TH ST CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BRINSON INC DATE OF NAME CHANGE: 19980910 FORMER COMPANY: FORMER CONFORMED NAME: UBS ASSET MANAGEMENT NEW YORK INC DATE OF NAME CHANGE: 19940125 SC 13G/A 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) SANGSTAT MEDICAL CORPORATION (Name of Issuer) - ----------------------------------------------------------- Common Stock (Title of Class of Securities) - ----------------------------------------------------------- 801003104 (CUSIP Number) - ----------------------------------------------------------- December 31, 1998 (Date of Event Which Requires Filing of this Statement) - ----------------------------------------------------------- Check the appropriate box to designate the rule pursuant to which this Schedule is filed: /x/ Rule 13d-1(b) / / Rule 13d-1(c) / / Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Page 1 of 6 pages Cusip 801003104 - ----------------------------------------------------------- 1 Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only). UBS Brinson, Inc. (formerly known as UBS Asset Management (New York) Inc. 13-2725861 - ----------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) a / / b /x/ See Item 8 of attached schedule. - ----------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------- 4 Citizenship or Place of Organization - New York - ----------------------------------------------------------- Number of 5. Sole Voting Power __________ Shares Bene- 6. Shared Voting Power 570,000 ficially 7. Sole Dispositive Power __________ Owned by Each 8. Shared Dispositive Power 570,000 Reporting Person With: - ----------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person 570,000 Shares * - ----------------------------------------------------------- 10 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - ----------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (11) 3.5% - ----------------------------------------------------------- 12 Type of Reporting Person (See Instructions) IA - ----------------------------------------------------------- * UBS Brinson, Inc. disclaims beneficial ownership of such securities. Page 2 of 6 pages Cusip 801003104 - ----------------------------------------------------------- 1 Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only). UBS AG 98-0186363 - ----------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) a / / b /x/ See Item 8 of attached schedule. - ----------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------- 4 Citizenship or Place of Organization - Switzerland - ----------------------------------------------------------- Number of 5. Sole Voting Power __________ Shares Bene- 6. Shared Voting Power 570,000 ficially 7. Sole Dispositive Power __________ Owned by Each 8. Shared Dispositive Power 570,000 Reporting Person With: - ----------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person 570,000 Shares * - ----------------------------------------------------------- 10 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - ----------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (11) 3.5% - ----------------------------------------------------------- 12 Type of Reporting Person (See Instructions) BK See Item 3 of attached schedule. - ----------------------------------------------------------- * UBS AG disclaims beneficial ownership of such securities. Page 3 of 6 pages Cusip 801003104 - ----------------------------------------------------------- Item 1(a). Name of Issuer: SANGSTAT MEDICAL CORPORATION Item 1(b). Address of Issuer's Principal Executive Offices: 1505 Adams Drive Menlo Park, CA 94025 - ----------------------------------------------------------- Item 2(a) Name of Persons Filing: UBS Brinson, Inc. ("UBS") and UBS AG ("UBSAG"). Item 2(b) Address of Principal Business Office or, if none, Residence: UBS's principal business office is located at: 10 E. 50th Street, New York, NY 10022 UBSAG's principal business office is located at: Bahnhofstrasse 45 8021, Zurich, Switzerland Item 2(c) Citizenship: Incorporated by reference to Item 4 of the cover pages. Item 2(d) Title of Class of Securities: Common Stock (the "Common Stock") Item 2(e) CUSIP Number: 801003104 - ----------------------------------------------------------- Item 3. Type of Person Filing: UBS is an Investment Adviser registered under section 203 of the Investment Advisers Act of 1940. UBS AG is classified as a Bank as defined in section 3(a)(6) of the Act pursuant to no action relief granted by the staff of the Securities and Exchange Commission. - ----------------------------------------------------------- Item 4 (a)-(c)(iv). Ownership: Incorporated by reference to Items 5-11 of the cover pages. - ----------------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following /X/. - ----------------------------------------------------------- Page 4 of 6 pages Cusip 801003104 - ----------------------------------------------------------- Item 6. Ownership of More than Five Percent on Behalf of Another Person: Accounts managed on a discretionary basis by UBS and/or UBS AG have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. No account holds more than 5 percent of the outstanding Common Stock. - ----------------------------------------------------------- Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: [See item 3 above] - ----------------------------------------------------------- Item 8 Identification and Classification of Members of the Group: UBS is an indirect wholly-owned subsidiary of UBS AG. UBS AG is reporting indirect beneficial ownership of holdings by reason of its ownership of UBS and UBS (USA) Inc., a parent holding company of UBS. UBS AG does not hereby affirm the existence of a group within the meaning of Rule 13d-5(b)(1). - ----------------------------------------------------------- Item 9 Notice of Dissolution of Group: Not Applicable - ----------------------------------------------------------- Item 10 Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. - ----------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: April 14, 1999 UBS Brinson, Inc. By:/s/ Mark F. Kemper By:/s/ Samuel W. Anderson Mark F. Kemper Samuel W. Anderson Secretary President UBS AG By: /s/ Louis R. Eber By:/s/ Janet R. Zimmer Louis R. Eber Janet R. Zimmer Executive Director Executive Director - ----------------------------------------------------------- Page 5 of 6 pages Cusip 801003104 - ----------------------------------------------------------- EXHIBIT 1 AGREEMENT TO MAKE A JOINT FILING UBS Brinson, Inc. and UBS AG each agrees that this Schedule 13G (including all amendments thereto) is filed by and on behalf of each such party. Date: April 14, 1999 UBS Brinson, Inc. By:/s/ Mark F. Kemper By:/s/ Samuel W. Anderson Mark F. Kemper Samuel W. Anderson Secretary President UBS AG By: /s/ Louis R. Eber By:/s/ Janet R. Zimmer Louis R. Eber Janet R. Zimmer Executive Director Executive Director Page 6 of 6 pages -----END PRIVACY-ENHANCED MESSAGE-----